Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03329950
Title A Study of CDX-1140 as Monotherapy or in Combination in Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Celldex Therapeutics
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
HonorHealth Research Insititute Scottsdale Arizona 85258 United States Details
Northside Hospital, Inc. Atlanta Georgia 30342 United States Details
Georgia Cancer Center at Augusta University Augusta Georgia 30912 United States Details
Oncology Hematology West, PC dba Nebraska Cancer Specialists Omaha Nebraska 68130 United States Details
Icahn School of Medicine at Mount Sinai New York New York 10029 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Gabrail Cancer Center Research LLC Canton Ohio 44718 United States Details
Providence Portland Medical Center Portland Oregon 97213 United States Details
Abramson Cancer Center at the University of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
Rhode Island Hospital (RIH) The Miriam Hospital (TMH) Providence Rhode Island 02903 United States Details
Houston Methodist Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field